Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity,Blood Cancer Journal

当前位置： X-MOL 学术 › Blood Cancer J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity
Blood Cancer Journal ( IF 12.8 ) Pub Date : 2024-02-06 , DOI: 10.1038/s41408-024-00988-x
Ioannis V. Kostopoulos , Despina Fotiou , Maria Gavriatopoulou , Pantelis Rousakis , Ioannis Ntanasis-Stathopoulos , Chrysanthi Panteli , Panagiotis Malandrakis , Magdalini Migkou , Nikolaos Angelis , Nikolaos Kanellias , Evangelos Eleutherakis-Papaiakovou , Foteini Theodorakakou , Maria Krevvata , Evangelos Terpos , Meletios-Athanasios Dimopoulos , Ourania Tsitsilonis , Efstathios Kastritis